# Tengion

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tengion

- Industry: Biotechnology
- Headquarters: Winston-Salem, US
- Website: www.tengion.com
- Total disclosed funding: $144M
- Latest round: Series C (Nov 19, 2008)
- Investors on record: 11

## About

Tengion is based in US and operates as a biotechnology company that engages in developing human tissues and organs.

## Funding rounds

- Series C, Nov 19, 2008, $21M — Oak Investment Partners, Safeguard Scientifics, Bain Capital, Quaker Partners Management, Johnson & Johnson Innovation, L Capital Partners, HealthCap, Deerfield Partners
- Series C, Sep 25, 2007, $33M — Oak Investment Partners, Bain Capital, Quaker Partners Management, HealthCap, Johnson & Johnson Innovation, L Capital Partners, Horizon Technology Finance Corporation, Oxford Finance Corporation, Deerfield Management
- Series B, Jun 27, 2006, $50M — Oak Investment Partners, Bain Capital, Quaker Partners Management, HealthCap, Johnson & Johnson Innovation, L Capital Partners
- Series A, Aug 1, 2005, $39M — Oak Investment Partners, HealthCap, Johnson & Johnson Innovation, L Capital Partners

## Investors

- Oak Investment Partners (https://capitalatlas.ai/funds/oak-investment-partners) — Series A, Series B, Series C
- HealthCap — Series A, Series B, Series C
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series A, Series B, Series C
- L Capital Partners (https://capitalatlas.ai/funds/l-capital-partners) — Series A, Series B, Series C
- Bain Capital (https://capitalatlas.ai/funds/bain-capital) — Series B, Series C
- Quaker Partners Management (https://capitalatlas.ai/funds/quaker-partners-management) — Series B, Series C
- Horizon Technology Finance Corporation — Series C
- Oxford Finance Corporation — Series C
- Deerfield Management (https://capitalatlas.ai/funds/deerfield-management) — Series C
- Safeguard Scientifics (https://capitalatlas.ai/funds/safeguard-scientifics) — Series C
- Deerfield Partners — Series C